Taysha Gene Therapies Stock (NASDAQ: TSHA) stock price, news, charts, stock research, profile.
Open | $2.15 |
Close | - |
Volume / Avg. | 1.18M / 2.14M |
Day Range | $2.04 - $2.15 |
52 Wk Range | 1.27 - 4.32 |
Market Cap | $419.11M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 13.94% |
Days to Cover | 24.68 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Taysha Gene Therapies (NASDAQ:TSHA) through any online brokerage.
Other companies in Taysha Gene Therapies’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Inozyme Pharma (NASDAQ:INZY), Larimar Therapeutics (NASDAQ:LRMR) and Sage Therapeutics (NASDAQ:SAGE).
Taysha Gene Therapies has a consensus price target of $7.13.
The stock price for Taysha Gene Therapies (NASDAQ: TSHA) is $2.045 last updated September 23, 2024 at 12:17 PM EDT.
There are no upcoming dividends for Taysha Gene Therapies.
Taysha Gene Therapies’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Taysha Gene Therapies.
Taysha Gene Therapies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.